Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Liver Diseases

Free Subscription Articles published in Dig Dis Retrieve available abstracts of 38 articles: HTML format Text format

Single Articles

January 2011
1. MEDINA JF
   Role of the anion exchanger 2 in the pathogenesis and treatment of primary biliary cirrhosis.
   Dig Dis. 2011;29:103-12.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. POUPON R
   Treatment of primary biliary cirrhosis with ursodeoxycholic Acid, budesonide and fibrates.
   Dig Dis. 2011;29:85-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. WILLIAMSON C , Miragoli M, Sheikh Abdul Kadir S, Abu-Hayyeh S, et al
   Bile Acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy.
   Dig Dis. 2011;29:58-61.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. PINZANI M
   Pathophysiology of non-alcoholic steatohepatitis and basis for treatment.
   Dig Dis. 2011;29:243-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. KUDO M , Izumi N, Kokudo N, Matsui O, et al
   Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version.
   Dig Dis. 2011;29:339-64.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. LEE HS
   Management of patients with hepatocellular carcinoma and extrahepatic metastasis.
   Dig Dis. 2011;29:333-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. HAYAISHI S , Chung H, Kudo M, Ishikawa E, et al
   Oral branched-chain amino Acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
   Dig Dis. 2011;29:326-32.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. UESHIMA K , Kudo M, Takita M, Nagai T, et al
   Des-gamma-Carboxyprothrombin May Be a Promising Biomarker to Determine the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma.
   Dig Dis. 2011;29:321-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. KUDO M
   Future treatment option for hepatocellular carcinoma: a focus on brivanib.
   Dig Dis. 2011;29:316-20.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. KUDO M
    mTOR Inhibitor for the Treatment of Hepatocellular Carcinoma.
    Dig Dis. 2011;29:310-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. KIM HY , Park JW
    Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stone.
    Dig Dis. 2011;29:303-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. KUDO M
    Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
    Dig Dis. 2011;29:289-302.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. YAMAZAKI K , Masugi Y, Sakamoto M
    Molecular Pathogenesis of Hepatocellular Carcinoma: Altering Transforming Growth Factor-beta Signaling in Hepatocarcinogenesis.
    Dig Dis. 2011;29:284-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. KIM JH , Yu SJ, Park BL, Cheong HS, et al
    TGFBR3 Polymorphisms and Its Haplotypes Associated with Chronic Hepatitis B Virus Infection and Age of Hepatocellular Carcinoma Occurrence.
    Dig Dis. 2011;29:278-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. KUDO M
    Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
    Dig Dis. 2011;29:273-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. BENSELER V , Tay SS, Bowen DG, Bertolino P, et al
    Role of the hepatic parenchyma in liver transplant tolerance: a paradigm revisited.
    Dig Dis. 2011;29:391-401.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. BOSSERHOFF A , Hellerbrand C
    Obesity and Fatty liver are 'grease' for the machinery of hepatic fibrosis.
    Dig Dis. 2011;29:377-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SCAGLIONI F , Ciccia S, Marino M, Bedogni G, et al
    ASH and NASH.
    Dig Dis. 2011;29:202-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. MARSCHALL HU , Wagner M, Zollner G, Fickert P, et al
    Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patients.
    Dig Dis. 2011;29:117-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. TRAUNER M , Baghdasaryan A, Claudel T, Fickert P, et al
    Targeting nuclear bile Acid receptors for liver disease.
    Dig Dis. 2011;29:98-102.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. KUBITZ R , Brinkmeyer C, Sagir A, Herebian D, et al
    Genetic variants of the bile salt export pump: inducers and modifiers of liver diseases.
    Dig Dis. 2011;29:89-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. MULLENBACH R , Lammert F
    An update on genetic analysis of cholestatic liver diseases: digging deeper.
    Dig Dis. 2011;29:72-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. OUDE ELFERINK RP , Kremer AE, Martens JJ, Beuers UH, et al
    The molecular mechanism of cholestatic pruritus.
    Dig Dis. 2011;29:66-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
24. 
    Imunology and liver diseases. Proceedings of the Falk Workshop 2009. Liver and metabolic syndrome. Proceedings of the Falk Symposium 171. October 15-18, 2009. Hannover, Germany. Workshop dedicated to the 80th birthday of Karl-Hermann Meyer zum Buesche
    Dig Dis. 2010;28:5-299.
    PubMed     Text format     Related articles   
    
    
    
    
25. CENTIS E , Marzocchi R, Di Domizio S, Ciaravella MF, et al
    The effect of lifestyle changes in non-alcoholic fatty liver disease.
    Dig Dis. 2010;28:267-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. MALLAT A , Lotersztajn S
    Endocannabinoids and their role in fatty liver disease.
    Dig Dis. 2010;28:261-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. DAY CP
    Genetic and environmental susceptibility to non-alcoholic fatty liver disease.
    Dig Dis. 2010;28:255-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. NEWTON JL
    Systemic symptoms in non-alcoholic fatty liver disease.
    Dig Dis. 2010;28:214-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. PERSEGHIN G
    The role of non-alcoholic fatty liver disease in cardiovascular disease.
    Dig Dis. 2010;28:210-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. YKI-JARVINEN H
    Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
    Dig Dis. 2010;28:203-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. BERRES ML , Nellen A, Wasmuth HE
    Chemokines as immune mediators of liver diseases related to the metabolic syndrome.
    Dig Dis. 2010;28:192-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. TILG H
    The role of cytokines in non-alcoholic fatty liver disease.
    Dig Dis. 2010;28:179-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. KANTARTZIS K , Schick F, Haring HU, Stefan N, et al
    Environmental and genetic determinants of fatty liver in humans.
    Dig Dis. 2010;28:169-78.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. CALDWELL S , Argo C
    The natural history of non-alcoholic fatty liver disease.
    Dig Dis. 2010;28:162-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. BELLENTANI S , Scaglioni F, Marino M, Bedogni G, et al
    Epidemiology of non-alcoholic fatty liver disease.
    Dig Dis. 2010;28:155-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. TRAUNER M , Fickert P, Baghdasaryan A, Claudel T, et al
    New insights into autoimmune cholangitis through animal models.
    Dig Dis. 2010;28:99-104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. MANNS MP
    Immunology and liver disease/liver and metabolic syndrome. Preface.
    Dig Dis. 2010;28:5-6.
    PubMed     Text format     Related articles   
    
    
    
    
38. KHOKHAR OS , Lewis JH
    Hepatotoxicity of agents used in the management of inflammatory bowel disease.
    Dig Dis. 2010;28:508-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: